Skip to main content

Kennen MacKay

Stock Analyst at RBC Capital

Total Price Targets
7
Stocks Covered
5
Sectors
Healthcare
Most Recent
Oct 16, 2024

Stocks Covered by Kennen MacKay

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
EXELExelixis, Inc.$34.00$43.81-22.4%1Oct 16, 2024
PRTAProthena Corporation plc$24.00$10.86+121.0%2Aug 9, 2024
NUVBNuvation Bio Inc.$5.00$4.50+11.2%1Apr 17, 2024
REGNRegeneron Pharmaceuticals, Inc.$638.00$703.72-9.3%2Jun 29, 2022
AMGNAmgen Inc.$218.00$328.69-33.7%1Feb 8, 2022

Recent Activity

  • Oct 16, 2024— Set$34.00price target onEXEL(Exelixis, Inc.)
  • Aug 9, 2024— Set$24.00price target onPRTA(Prothena Corporation plc)
  • May 9, 2024— Set$28.00price target onPRTA(Prothena Corporation plc)
  • Apr 17, 2024— Set$5.00price target onNUVB(Nuvation Bio Inc.)
  • Jun 29, 2022— Set$638.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
  • Feb 8, 2022— Set$218.00price target onAMGN(Amgen Inc.)
  • Feb 4, 2022— Set$679.00price target onREGN(Regeneron Pharmaceuticals, Inc.)

Frequently Asked Questions

Who is Kennen MacKay?

Kennen MacKay is a stock analyst at RBC Capital covering 5 stocks primarily in Healthcare. They have issued 7 price targets since Feb 4, 2022.

What stocks does Kennen MacKay cover?

Kennen MacKay currently covers 5 stocks, including PRTA, REGN, EXEL, NUVB, AMGN.

What is Kennen MacKay's latest price target?

Kennen MacKay's most recent price target was $34.00 on EXEL (Exelixis, Inc.), set on Oct 16, 2024.

What is Kennen MacKay's highest price target?

Kennen MacKay's highest issued price target is $679.00 on REGN, set on Feb 4, 2022.

Coverage based on publicly published price targets. Not investment advice.